AUTHOR INDEX. Note: The appearance of "(s)" after a page number indicates that the author's work appears in a supplement.

Transcription

1 AUTHOR INDEX Note: The appearance of "(s)" after a page number indicates that the author's work appears in a supplement. Acchiardo, S., 105 Gallagher, C., 81 Peraglie, C., 96 Allman, MA, 59 Gammarino, M., 30 Price, R.N., 27(s) Averbach, F.M., 117 Gee, C., 154 Przygrodzka, F., 18(s) Gillis, B.P., 117 Bansal, V.K., 8(s), 27(s), 28 Gotch, FA, 154 Rayner, H.C., 18(s) Bellisle, F., 42(s) Grace-Farfaglia, P., 67 Reams, S., 18 Berkseth, R.O., 146 Beto, JA, 1, 27(s), 28, 32, 49, 95, Hadfield, C., 37(s) 145,176,179 Sandroni, S., 33(s) Hensley, M.K., 1 (s) Bissler,G.M., 171, 176 Sargent, JA, 105 Horvath, J.S., 59 Boyle, G., 13(s) Schmitt, J., 126 Brown, C.B., 13(s) Shapiro, AC., 13 Ishkanian, I., 161 Broyer, M., 42(s) Smathers, J.S., 33(s) Brucia, J., 131 Smith, C.L., 146 Jacob, V., 13(s) Burden, R.P., 18(s) Smith, RD., 96 James, M.E., 81 Burk, L., 105 Steiner, T., 81 Jenkins, J.H., 113 Stewart, P.M., 59 Jones, F.L., 117 Caggiula, AW., 117 Juneja, V., 165, 174 Chan, J.C.M., 2 Tiller, D.J., 59 Chandrasekhar, AJ., 27(s) Torrington, J., 113 Kaysen, GA, 50 Cochran, C., 79 Truswell, AS., 59 Kurtin, P.S., 13 Cohen, BA, 129 Coleman, J.E., 21 (s) Liepa, G.U., 96 Van Beber, AD., 96 Coles, GA, 113 Vennegoor, M., 1 (s) Craven, C., 67 Littlefield, D., 30, 179 Vizioli, T.L., 161 Dartois, AM., 42(s) Massie, MD., 2 Davis, M., 32,146 Medford, S., 77 Watson, AR., 21 (s) Do Carmo, S., 171, 176 Moles, K., 33(s) Wild, G., 13(s) Donovan, L., 171, 176 Moore, L.w., 105 Witt, J.E., 71 Duggin, G.G., 59 Moorhead, P.J., 13(s) Wolff, M.J., 23 Morgan, AG., 18(s) EI Nahas, AM., 2(s), 13(s) Murphy, L., 67 Yamamoto, M.E., 117 Yang,w.,2 Fedje, L., 131 Niimi, K., 2 Yau, D.F., 59 Note: The appearance of "(s)" after a page number indicates that the subject appears in a supplement. Acute renal failure growth hormone therapy in, 4(s), 5(s) insulin-like growth factor-i in, 4(s), 5(s) Albumin homeostasis in nephrotic syndrome, 51 related to serum calcium level changes, 32 serum level as predictor of death, 35(s) Aluminum in over-the-counter antacids, 81 Amino acids dietary glucose polymer supplement and plasma, measurement of, 61,62 Amino acids (Continued) recombinant human erythropoietin therapy effect on, 101 Anemia iron deficiency in hemodialysis patients, Anemia of end-stage renal disease development of recombinant human erythropoietin, 97- laboratory characteristics of, 97 recombinant human erythropoietin therapy for, relation with erythropoietin, kidney disease, and, 97 Antacids type of calcium carbonate in over-the-counter, 81 Journal of Renal Nutrition, Vol 2, No 4 (October). 12: pp

2 196 Anthropometric indicators changes after dietary glucose polymer supplement, in children with chronic renal insufficiency, 4-6 in hemodialysis v CAPD patients, 14(s), 15(s) in idiopathic calcium oxalate lithiasis, Ascorbic acid in diet of iron deficiency anemia patients, 110, 111 Biochemical assessment parameters in children with chronic renal insufficiency, 7, 8 in hemodialysis v CAPD patients, 16(s) Blood constituents in children with chronic renal insufficiency, 6-9 Blood loss iron deficiency anemia in hemodialysis patients, Blood urea nitrogen residual renal function in hemodialysis patients, Body weight measurement in children with chronic renal insufficiency, 5 Calcium albumin-related changes in levels of serum, 32 intake in calcium nephrolithiasis, 148 Calcium carbonate effect of brand of on phosphorus levels, in over-the-counter antacids, 81 Calcium glutamate as potassium-free sodium substitute in children, 42(s)-46(s) Calcium nephrolithiasis calcium intake, 148 dietary factors in, dietary protein, 149 fiber intake, 149, 150 fluid intake, 147 magnesium, 150 oxalate, 148, 149 phosphorus, 148 physical chemistry, 147 refined sugars, 150 sodium intake, 147 therapy, 150, 151 Calcium oxalate lithiasis baseline information and metabolic evaluation, 169 idiopathic in recurrent stone-forming patient, Caloric supplementation effect on growth of children with renal disease, Calories intake in low-protein diet, 37(s)-41 (s) CAPD, see Continuous ambulatory peritoneal dialysis patients Case studies idiopathic calcium oxalate lithiasis, ingestion of phosphate-containing laxative, Catabolism hyperkalemia due to increased, 10(s) Children, see Pediatrics Cholesterol-lowering drugs role in dialysis and renal failure patients, 81, 82 Chronic renal failure developing patient education materials for, dietary/nondietary etiology of hyperkalemia in, 28, 29 gastrostomy buttons for children with, 21 (s)-26(s) growth hormone therapy in, 5(s) ingestion of phosphate-containing laxative in, insulin-like growth factor-i in, 5(s) potassium metabolism in, 8(s)-12(s) Chronic renal insufficiency in children anthropometric indicators, 4-6 biochemical assessment parameters, 7, 8 blood constituents, 6-9 dietary history, 3, 4 nutritional assessment, 2-12 physical examination, 4 psychosocial assessment, 3 trace mineral analysis, 9 urinary constituents, 9 Continuous ambulatory peritoneal dialysis patients effect of dialysate on food consumption by, nutrition in v hemodialysis patients, 13(s)-17(s) Continuous cycling peritoneal dialysis gastrostomy buttons in children undergoing, 21 (s)- 26(s) Cookbook(s) for dialysis patients, 131, 132 Creatinine clearance and residual renal function, calculation of, 157, 158 Diabetes, type I nutrition in pancreas-renal transplantation for, Dialysate(s) effect on food consumption by CAPD patients, Dialysis hyperkalemia and adequacy of, 11 (s) information system to track nutritional data, 27(s)- 32(s) Dialysis patients use of cholesterol-lowering drugs in, 81,82 Diet intervention program effect on growth in children with renal disease, Diet(s) for renal patients calculating nutrient content of watermelon, 32 cookbooks for dialysis patients, 131, 132 developing patient education materials for, handout on meal and medicine schedule, 129, 130 iron deficiency anemia in hemodialysis patients, kidney stone diet patient handout, 174, 175 management of nephrotic syndrome, Modification of Diet in Renal Disease study,

3 Diet(s) for renal patients (Continued) nutritional adequacy of low-protein diet, 37(s)-41 (s) phosphorus patient education handout, 30, 31 production of quality dietary data, variations in nutritional information for, 131 Dietary data importance and difficulties of quality control, 118 Modification of Diet in Renal Disease study on, Dietary history in children with chronic renal insufficiency, 3, 4 Dietitian(s), see Renal dietitian(s) Drug effects on hyperkalemia in renal failure, 1 O(s), 11 (s) Education continuing for renal dietitians, 176 see also Patient education Electrolyte abnormalities severe due to phosphate-containing laxative, End-stage renal disease growth hormone therapy in, 5(s) insulin-like growth factor-i in, 5(s) laboratory characteristics of anemia of, 97 medical review criteria and dietitian's checklist, 77, 78 new FDA food labels and implications for, recombinant human erythropoietin for anemia of, Endocrine factors hyperkalemia due to in renal failure, 10(s) Energy requirements and growth in children with renal disease, Energy supplementation dietary glucose polymer effect on amino acids, Erythropoietin relationship with kidney disease and anemia, 97 see also Recombinant human erythropoietin ESRD, see End-stage renal disease Exercise bibliography of references for renal population, effect on hyperkalemia in renal failure, 11 (s), 12(s) post-renal transplant program, Fiber intake in calcium nephrolithiasis, 149, 150 Fluid intake in calcium nephrolithiasis, 147 Food and Drug Administration food labeling proposals cost savings, 75, 76 definitions, 74 food label format, 75 health claims, 74 implications of for renal dietitians, ingredient labeling, 74, 75 state preemption, 75 timetable, 75 Food consumption effect of dialysate on in CAPO patients, Food consumption (Continued) handout on meal and medicine schedule, 129, 130 Food label(s) comparison chart of standards used in, 73 new FDA requirements for, Frozen foods product update and nutrient analysis, 33, 34, 83, 84,133,134,180,182 Gastrostomy buttons in children with chronic renal failure, 21 (s)-26(s) Glucose polymer supplementation and plasma amino acids in hemodialysis patients, Growth hormone and insulin-like growth factor-i and the kidney, 2(s)-7(s) future directions, 5(s), 6(s) in acute renal failure, 4(s) in chronic renal failure, 5(s) in end-stage renal failure, 5(s) kidney scarring and, 3(s) mechanism of action, 5(s) Growth retardation effect of defined caloric supplementation, Head circumference in children with chronic renal insufficiency, 6 Heart disease and post-renal transplant exercise program, Hemodialysis patient(s) after recombinant human erythropoietin therapy, blood loss in, 109 dietary glucose polymer supplementation in, effect of brand of calcium carbonate product, hematologic values before/after IV or PO iron in, 109 ingestion of phosphate-containing laxative by, iron deficiency anemia in, measurement of residual renal function in, nutrition in v CAPO patients, 13(s)-17(s) plasma amino acids and nutrition in, predicted iron losses in, 110 Hypercalciuria in idiopathic calcium oxalate lithiasis, Hyperkalemia adequacy of dialysis and, 11 (s) dietary and nondietary etiology, 28, 29 due to drug effects, 1 O(s), 11 (s) due to endocrine considerations, 10(s) due to increased catabolism, 10(s) due to transcellular shift, 9(s), 10(s) effect of exercise, 11 (s), 12(s) nondietary rationale for in renal failure, 8(s)-12(s) Hyperlipidemia endogenous of nephrotic syndrome, 54, 55 Hyperphosphatemia after ingestion of phosphate-containing laxative,

4 198 Hypertension due to recombinant human erythropoietin therapy, Hyperuricosuria in idiopathic calcium oxalate lithiasis, Hypocalcemia after ingestion of phosphate-containing laxative, Immunosuppression after pancreas-renal transplantation, 162 Information systems local area network-based to track nutritional data, 27(s)-32(s) Insulin-like growth factor-i and growth hormone and the kidney, 2(s)-7(s) and growth hormone therapy in renal disease, 4(s), 5(s) future directions, 5(s), 6(s) in acute renal failure, 4(s), 5(s) in chronic renal failure, 5(s) in end-stage renal failure, 5(s) kidney function and, 3(s) kidney growth and, 2(s), 3(s) kidney scarring and, 3(s) mechanism of action, 5(s) nutrition in renal disease and, 4(s) nutritional marker in CAPO patients, 13(s)-17(s) uremic complications and, 3(s), 4(s) Iron IV v PO in treating anemic hemodialysis patients, oral supplements, 127 patient handout for meal and medicine schedule, 129,130 selection of appropriate supplement, Iron deficiency anemia causes and treatment in hemodialysis patients, Journal of Renal Nutrition as a professional support group, 49 diversity in renal nutrition, 95 editorial decisions for, 1 new structured abstract format, 145 Kidney disease, see Renal disease and specific types Kidney stone(s), see Renal stone(s) Kidney transplantation, see Renal transplantation Kidney(s) insulin-like growth factor-i, growth hormone and, 2(s)-7(s) Laxative(s) hyperphosphatemia due to phosphate-containing, Lipids effects on renal disease, 52, 53 Lithiasis, see Calcium oxalate lithiasis Local area network-based information system for tracking nutritional data on dialysis patients, 27(s)-32(s) Low-protein diet(s) nutritional adequacy of, 37(s)-41 (s) Magnesium in calcium nephrolithiasis, 150 in over-the-counter antacids, 81 Malnutrition improving protein intake in peritoneal dialysis, 33(s)- 36(s) in children with chronic renal insufficiency, 2-12 Medical review criteria dietitian's checklist for end-stage renal disease, 77, 78 Medicine(s), see Prescription medicine(s) Metabolic acidosis in hemodialysis patients, 13(s)-17(s) Mid-arm circumference in children with chronic renal insufficiency, 5, 6 Milk substitutes product update and nutrient analysis, 83, 84 Minerals intake in low-protein diet, 37(s)-41 (s) recombinant human erythropoietin therapy effect on, 101 Modification of Diet in Renal Disease Study food record form, 1 20 production of quality dietary data, study participants, 123, 124 Nephrolithiasis, see Calcium nephrolithiasis Nephrotic syndrome albumin homeostasis in, 51 effects of lipids on renal disease, 52, 53 effects on solid tissue protein homeostasis, 51, 52 endogenous hyperlipidemia of, 54, 55 nutritional management of, polyunsaturated fatty acids, 53, 54 urinary loss of nonalbumin plasma proteins, 52 Nutrient content calculating for watermelon, 32 Nutrition in hemodialysis v CAPO patients, 13(s)-17(s) in pancreas-renal transplantation, patient handout on goals after kidney transplant, 79,80 Nutrition Labeling and Education Act implications of for renal dietitians, Nutritional assessment of children with chronic renal insufficiency, 2-12 Nutritional status changes after successful renal 1ransplantation, 18(s)-20(s) dietary glucose polymer supplementation effect on, Nutritional support via gastrostomy buttons in children, 21 (s)-26(s)

5 Obesity serious after successful renal transplantation, 18(s)- 20(s) Oxalate in calcium nephrolithiasis, 148, 149 Pancreas-renal transplantation acute posttransplant period nutrition, 162 chronic posttransplant period nutrition, 162, 163 complications, 163, 164 history and surgical technique, 161, 162 immunosuppression, 162 implications, 164 nutrition in, Patient education designing renal nutrition education materials, 19, 20 developing and presenting materials for renal, developing renal nutrition instruction materials, 19 factors affecting dietary adherence, 18, 19 goals for good nutrition after kidney transplant, 79, 80 kidney stone diet, 174, 175 meal and medicine schedule, 129, 130 phosphorus, 30, 31 using renal nutrition education materials, 20, 21 variations in nutritional information on handouts, 131 Pediatrics calcium glutamate as sodium substitute, 42(s)- 46(s) defined caloric supplementation and growth, gastrostomy buttons in chronic renal failure, 21 (s)- 26(s) nutrition assessment in chronic renal insufficienc, 2-12 Peritoneal dialysis staff-assisted, in-center, 35(s) strategies to improve protein intake in patients, 33(s)-36(s) Phosphate binders patient handout on meal and medicine schedule, 129,130 Phosphate-containing laxative severe hyperphosphatemia/hypocalcemia due to, Phosphorus correction on patient education handout, 179 effect of brand of calcium carbonate product on, in calcium nephrolithiasis, 148 patient education handout, 30, 31 Physical examination in children with chronic renal insufficiency, 4 Plasma amino acids dietary glucose polymer supplement effect on, Plasma proteins effects of urinary loss of nonalbumin, 52 Polyunsaturated fatty acids in nephrotic syndrome, 53, 54 1 Potassium in diet for iron deficiency anemia patients, 110, 111 metabolism in renal failure, 8(s)-12(s) potassium-free sodium substitute for children, 42(s)- 46(s) variations in nutritional information for patients, 131 Prescription medicine(s) patient handout on meal and medicine schedule, 129,130 Proceedings, see Sixth International Congress Product updates Betty Crocker fruit snacks, 180, 181 Budget Gourmet Light and Healthy Dinners, 33, 34 Campbell's Healthy Request soups, 133 Healthy Choice breakfast sandwiches, 33, 34 Healthy Choice soups and frozen foods, 133, 134 Healthy Choice shelf-stable meals, 180, 182 Kraft Eating Right products, 33, 34 Le Menu Healthy frozen dinners, 33, 34 Le Menu Healthy frozen entrees, 180, 182 milk substitutes and nondairy products, 83, 84 sodium-controlled soups, 133, 134 Protein homeostasis effects of nephrotic syndrome on solid tissue, 51, 52 Protein intake change in dialysis modality and, 35(s) dietary in calcium nephrolithiasis, 149 nutritional adequacy of low-protein diet, 37(s)-41 (s) parenteral supplementation, 35(s) special protein module supplementation, 34(s), 35(s) staff-assisted, in-center peritoneal dialysis, 35(s) strategies to improve in peritoneal dialysis, 33(s)- 36(s) Psychosocial assessment in children with chronic renal insufficiency, 3 Quality control Modification of Diet in Renal Disease study on, Recombinant human erythropoietin development of for treatment of anemia of ESRD, 97- effect in anemic kidney patients, effects on vitamin and mineral needs, 101 effects on amino acids, 101 hypertension due to therapy for anemia of uremia, iron deficiency anemia before therapy with, nutritional consequences of,, 100 selection of appropriate iron supplement before, subjective changes in hemodialysis patients after, Recommended Daily Allowance (RDA) for energy intake growth in children with renal disease, Refined sugars in calcium nephrolithiasis, 150

6 200 Renal diet, see Diets for renal patients Renal dietitian(s) checklist for end-stage renal disease, 77, 78 continuing education for, 1 76 implications of 21 st century food labels for, renal specialist certification, 176 Renal disease caloric supplementation and growth in children, growth hormone therapy in, 4(s), 5(s) insulin-like growth factor-i and nutrition in, 4(s) relation between erythropoietin, anemia, and, 97 Renal failure potassium metabolism in, 8(s)-12(s) role of cholesterol-lowering drugs in, 81, 82 see also Acute and Chronic renal failure Renal function measurement of residual in hemodialysis patients, Renal insufficiency, chronic, see Chronic renal insufficiency Renal stone(s) dietary factors in calcium nephrolithiasis, patient handout for kidney stone diet, 174, 175 risk factors for formation of, 174 Renal transplantation nutritional status changes after successful, 18(s)- 20(s) patient handout on good nutrition goals after, 79, 80 posttransplant exercise program, see also Pancreas-renal transplantation Residual renal function measurement of in hemodialysis patients, Serum calcium levels albumin-related changes in, 32 Serum phosphorus levels effect of brand of calcium carbonate product on, Sixth International Congress on Nutrition and Metabolism in Renal Disease abstracts, 47(s)-50(s) calcium glutamate as sodium substitute in children, 42(s)-46(s) gastrostomy buttons in children, 21 (s)-26(s) guest editorial, 1 (s) improving protein intake in peritoneal dialysis, 33(s)- 36(s) insulin-like growth factor and growth hormone, 2(s)-7(s) nutrition in hemodialysis v CAPO patients, 13(s)- 17(s) Sixth International Congress on Nutrition and Metabolism in Renal Disease (Continued) nutritional status changes after renal transplant, 18(s)-20(s) nutritional adequacy of low-protein diet, 37(s)-42(s) potassium metabolism in renal failure, 8(s)-12(s) tracking nutritional data on dialysis patients, 27(s)- 32(s) Skinfold thickness in children with chronic renal insufficiency, 5, 6 Sodium calcium glutamate as potassium-free substitute for, 42(s)-46(s) intake in calcium nephrolithiasis, 147 product update on sodium-controlled soups, 133, 134 Statural measurement in children with chronic renal insufficiency, 5 Stone(s), see Renal stone(s) Sugar(s) refined in calcium nephrolithiasis, 150 Trace mineral analysis in children with chronic renal insufficiency, 9 Urea clearance calculation of, 157, 158 measurement of residual renal, Uremia hypertension from recombinant human erythropoietin, insulin-like growth factor-i and, 3(s), 4(s) potassium-free sodium substitute for children, 42(s)- 46(s) Urinary constituents in children with chronic renal insufficiency, 9 Urinary loss of proteins in nephrotic syndrome, Urinary risk factors in idiopathic calcium oxalate lithiasis, Urolithiasis, seecalcium oxalate lithiasis Vitamins intake in low-protein diet, 37(s)-41 (s) recombinant human erythropoietin therapy effect on, 101 Watermelon calculating nutrient content of, 32 Weight gain after successful renal transplantation, 18(s)-20(s)